Antiretroviral treatment among commercially insured persons living with HIV in an era of universal treatment in the United States – 2012–2014

References

• Althoff, K. N., Buchacz, K., Hall, H. I., Zhang, J., Hanna, D. B., Rebeiro, P., … Design. (2012). U.S. Trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Annals of Internal Medicine, 157(5), 325–335. doi: 10.7326/0003-4819-157-5-201209040-00005
   PubMed Web of Science ®Google Scholar
• Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M., & Moss, A. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26(5), 435–442. doi: 10.1097/00042560-200104150-00005
   PubMed Web of Science ®Google Scholar
• Bradley, H., Viall, A. H., Wortley, P. M., Dempsey, A., Hauck, H., & Skarbinski, J. (2016). Ryan white HIV/AIDS program assistance and HIV treatment outcomes. Clinical Infectious Diseases, 62(1), 90–98. doi: 10.1093/cid/civ708
   PubMed Web of Science ®Google Scholar
• Byrd, K. K., Furtado, M., Bush, T., & Gardner, L. (2016). Reengagement in care after a Gap in HIV care Among a population of privately insured persons with HIV in the United States. AIDS Patient Care and STDs, 30(11), 491–496. doi: 10.1089/apc.2016.0188
   PubMed Web of Science ®Google Scholar
• Carter, M. W., Wu, H., Cohen, S., Hightow-Weidman, L., Lecher, S. L., & Peters, P. J. (2016). Linkage and referral to HIV and other medical and social services: A focused literature review for sexually transmitted disease prevention and control programs. Sexually Transmitted Diseases, 43(Suppl 1), S76–82. doi: 10.1097/OLQ.0000000000000290
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. HIV Surveillance Report. (2016a). Behavioral and clinical characteristics of persons receiving medical care for HIV infection—medical monitoring project, United States, 2013 cycle (June 2013–May 2014). (HIV Surveillance Special Report 16).
   Google Scholar
• Centers for Disease Control and Prevention. HIV Surveillance Report. (2016b). HIV Surveillance Report. 27.
   Google Scholar
• Chander, G., Himelhoch, S., & Moore, R. D. (2006). Substance abuse and psychiatric disorders in HIV-positive patients: Epidemiology and impact on antiretroviral therapy. Drugs, 66(6), 769–789. doi: 10.2165/00003495-200666060-00004
   PubMed Web of Science ®Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … Team, H. S. (2016). Antiretroviral therapy for the prevention of HIV-1 transmission. New England Journal of Medicine, 375(9), 830–839. doi: 10.1056/NEJMoa1600693
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services (DHHS). (2009). Panel on antiretroviral guidelines for adults and adolescents: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents.
   Google Scholar
• Department of Health and Human Services (DHHS). (2012). Panel on antiretroviral guidelines for adults and adolescents: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Author.
   Google Scholar
• Department of Health and Human Services (DHHS). (2013). Panel on antiretroviral guidelines for adults and adolescents: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Author.
   Google Scholar
• Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011). Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 58(2), 181–187. doi: 10.1097/QAI.0b013e31822d490a
   PubMed Web of Science ®Google Scholar
• Hansen L, C. S. (2011). White Paper—Health Research Data for the Real World: The MarketScan® Databases. Truven Health Analytics.
   Google Scholar
• Haubrich, R. H., Little, S. J., Currier, J. S., Forthal, D. N., Kemper, C. A., Beall, G. N., … McCutchan, J. A. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS, 13(9), 1099–1107.
   Google Scholar
• Health and Human Services (HHS). (2017, September). Hiv treatment as prevention. Department of Health and Human Services.
   Google Scholar
• Health and Human Services (HHS). The AIDS drug assistance program (ADAP). Department of Health and Human Services.
   Google Scholar
• Kastner, M., Estey, E., Perrier, L., Graham, I. D., Grimshaw, J., Straus, S. E., … Bhattacharyya, O. (2011). Understanding the relationship between the perceived characteristics of clinical practice guidelines and their uptake: Protocol for a realist review. Implementation Science, 6, 1082. doi: 10.1186/1748-5908-6-69
   Web of Science ®Google Scholar
• Kelly, J. D., Hartman, C., Graham, J., Kallen, M. A., & Giordano, T. P. (2014). Social support as a predictor of early diagnosis, linkage, retention, and adherence to HIV care: Results from the steps study. Journal of the Association of Nurses in AIDS Care, 25(5), 405–413. doi: 10.1016/j.jana.2013.12.002
   PubMed Web of Science ®Google Scholar
• Langebeek, N., Gisolf, E. H., Reiss, P., Vervoort, S. C., Hafsteinsdottir, T. B., Richter, C., … Nieuwkerk, P. T. (2014). Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: A meta-analysis. BMC Medicine, 12(142). doi: 10.1186/PREACCEPT-1453408941291432
   PubMedGoogle Scholar
• Lodi, S., Sharma, S., Lundgren, J. D., Phillips, A. N., Cole, S. R., Logan, R., … INSIGHT Strategic Timing of AntiRetroviral Treatment (START) study group. (2016). The per-protocol effect of immediate vs. Deferred ART initiation in the START randomized trial. Aids (london, England). doi: 10.1097/QAD.0000000000001243
   PubMed Web of Science ®Google Scholar
• Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., … Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21–30. doi: 10.7326/0003-4819-133-1-200007040-00004
   PubMed Web of Science ®Google Scholar
• Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J. C., … Ghali, W. A. (2005). Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care, 43(11), 1130–1139. doi: 10.1097/01.mlr.0000182534.19832.83
   PubMed Web of Science ®Google Scholar
• Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., van Lunzen, J., … PARTNER Study Group. (2016). Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner Is using suppressive antiretroviral therapy. JAMA, 316(2), 171–181. doi: 10.1001/jama.2016.5148
   PubMed Web of Science ®Google Scholar
• Skarbinski, J., Rosenberg, E., Paz-Bailey, G., Hall, H. I., Rose, C. E., Viall, A. H., … Mermin, J. H. (2015). Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Internal Medicine, 175(4), 588–596. doi: 10.1001/jamainternmed.2014.8180
   PubMed Web of Science ®Google Scholar
• Weiser, J., Brooks, J. T., Skarbinski, J., West, B. T., Duke, C. C., Gremel, G. W., & Beer, L. (2016). Barriers to universal prescribing of antiretroviral therapy by HIV care providers in the United States, 2013-2014. Journal of Acquired Immune Deficiency Syndromes. doi: 10.1097/QAI.0000000000001276
   PubMed Web of Science ®Google Scholar